UNSPSC 51373315: Acetaminophen/pentazocine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51373315 Acetaminophen/pentazocine is a Commodity-tier code, but the recent state and local solicitations tagged under it diverge materially from its nominal scope. The code's name references a specific pharmaceutical combination product, yet the recent opportunities posted under this code solicit naloxone and drug deactivation systems (Seminole County, Florida), therapeutic pharmacy initiative direct-to-manufacturer prescription programs (Texas Health and Human Services Commission), and broad generic multi-source pharmaceuticals and OTC products (Minnesota Multistate Cooperative Purchasing Alliance). The work actually being bought reflects state and local health agencies' procurement of pharmaceuticals and ancillary health-related products through competitive bidding and cooperative purchasing vehicles, rather than purchases of the acetaminophen/pentazocine combination specifically. Issuers include county health departments, state health and human services agencies, and multistate cooperative purchasing organizations serving participating state and local facilities.

Recent activity spans Florida, Texas, and Minnesota, with the cooperative purchasing structure extending to Oregon and other participating jurisdictions. The Seminole County IFB (Solicitation IFB60459723LAS, due July 26, 2023) seeks annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries, fixed-fee pricing, a two-year initial term with one-year renewal option, and potential FEMA funding. The Texas HHS Commission RFI (HHS0017013, posted April 3, 2026) gathers market intelligence on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and wholesaler arrangements. The Minnesota MMCAP RFP (S1070000015802, due March 26, 2026) establishes multi-award contracts for generic pharmaceuticals and OTC products distributed through three authorized wholesalers, with pricing weighted at 75 percent of evaluation and contract effectiveness July 1, 2026. The mismatch between the code's narrow pharmaceutical-combination name and the breadth of solicited work suggests this code may be receiving miscategorized opportunities in state and local procurement systems.